Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
Authors:
Open Access
- 28 September 2010
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 103 (8) , 1192-1200
Abstract
Background: Methods: Results: Conclusions:Keywords
This publication has 30 references indexed in Scilit:
- Drug Resistance Caused by Reversion MutationCancer Research, 2008
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesEuropean Journal of Cancer, 2007
- Role of chemotherapy resistance genes in outcome of neuroblastomaPediatric Blood & Cancer, 2007
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell lineMolecular Cancer Therapeutics, 2006
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reactionEndocrine-Related Cancer, 2004
- Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragmentsHuman Mutation, 2002
- Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.1995